177 related articles for article (PubMed ID: 11020857)
1. Characteristics of sarcomatous cholangiocarcinoma of the liver.
Shimada M; Takenaka K; Rikimaru T; Hamatsu T; Yamashita Y; Kajiyama K; Taguchi K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2000; 47(34):956-61. PubMed ID: 11020857
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic sarcomatoid cholangiocarcinoma: clinical analysis of seven cases during a 15-year period.
Tsou YK; Wu RC; Hung CF; Lee CS
Chang Gung Med J; 2008; 31(6):599-605. PubMed ID: 19241900
[TBL] [Abstract][Full Text] [Related]
3. Sarcomatous cholangiocarcinoma.
Gupta K; Powari M; Dey P
Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
[No Abstract] [Full Text] [Related]
4. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
[TBL] [Abstract][Full Text] [Related]
6. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
7. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma with sarcomatous transformation: an autopsy case.
Sasaki M; Nakanuma Y; Nagai Y; Nonomura A
J Clin Gastroenterol; 1991 Apr; 13(2):220-5. PubMed ID: 1851775
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
[TBL] [Abstract][Full Text] [Related]
12. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
[TBL] [Abstract][Full Text] [Related]
13. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
[TBL] [Abstract][Full Text] [Related]
14. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
15. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
18. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
20. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
